These studies will be key toward determining if mTOR suppression in T cells is a viable target for treating autoimmunity, cancers, and infectious diseases, or for boosting memory CD8+ T cell responses to enhance vaccine efficacy. The gene discussed is MTOR; the disease is infectious disease.